Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes
暂无分享,去创建一个
I. Najm | C. Bien | R. Coras | K. Kobow | Samir Jabari | T. Pieper | M. Kudernatsch | T. Kalbhenn | K. Rössler | C. Leu | H. Hamer | T. Hartlieb | P. Nürnberg | Sebastian Brandner | J. A. López-Rivera | D. Lal | Patrick N. Harter | L. Hoffmann | Patrick N Harter | Jochen Herms | Markus Müller | Ingmar Blümcke | M. Müller